Semnur Pharmaceuticals, Inc. Accounts Payable and Accrued Liabilities, Current
Semnur Pharmaceuticals, Inc. (SMNR) had Accounts Payable and Accrued Liabilities, Current of $3.34 million as of 2023-06-30, per its 10-Q filed 2023-08-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2023-08-15
- 2023-06-30: Accounts Payable and Accrued Liabilities, Current $3.34M.
- 2023-03-31: Accounts Payable and Accrued Liabilities, Current $2.98M.
- 2022-12-31: Accounts Payable and Accrued Liabilities, Current $1.29M.
- 2022-09-30: Accounts Payable and Accrued Liabilities, Current $90.80K.
| Period end | Accounts Payable and Accrued Liabilities, Current |
|---|---|
| 2023-06-30 | $3.34M 10-Q · filed 2023-08-15 |
| 2023-03-31 | $2.98M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.29M 10-Q · filed 2023-08-15 |
| 2022-09-30 | $90.80K 10-Q · filed 2022-11-16 |
| 2022-06-30 | $82.30K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $133.21K 10-Q · filed 2022-05-23 |